Portal vein thrombosis (PVT) is one of the severe complications of liver cirrhosis.\[[@ref1][@ref2][@ref3]\] It is defined as the formation of a thrombus within the portal vein trunk and intrahepatic portal branches. The reported prevalence of PVT ranges from 0.6% to 26% in liver cirrhosis.\[[@ref1][@ref2][@ref3][@ref4][@ref5][@ref6][@ref7][@ref8]\] PVT deteriorates the liver dysfunction, increases the risk of bleeding, and influences the prognosis of patients with liver cirrhosis.\[[@ref1][@ref2][@ref3]\] Development of PVT is associated with systemic prothrombotic factors and local risk factors.\[[@ref9][@ref10][@ref11]\] Systemic risk factors include factor V Leiden mutation, G20210A prothrombin mutation, MTHFR C667T mutation, lupus anticoagulant, decreased level of proteins C and S and antithrombin III, and increased levels of factor VIII. Local factors include inflammatory lesions, pancreatitis, splenomegaly, a large splenic vein diameter, reduced portal flow velocity, and increased flow volume in the largest collateral vessel.\[[@ref1][@ref2][@ref3][@ref4][@ref5][@ref6][@ref7][@ref8]\] D-dimer level can reflect the fibrinolytic activity in humans, and is elevated in patients with deep vein thrombosis and pulmonary embolism due to the activation of fibrinolysis system. Recently, one study by Zhang *et al.* has also shown that D-dimer testing with a cutoff value of 0.24 mg/L has a high sensitivity of 100% and a negative predictive value of 100% in excluding a diagnosis of PVT.\[[@ref12]\] But the specificity and predictive value are low (30.7% and 16.7%).\[[@ref12]\] In addition, the association between D-dimer level and the presence of PVT was not supported by some studies.\[[@ref13]\] Herein, we do a meta-analysis to detect the role of D-dimer in the development of PVT in liver cirrhosis.

MATERIALS AND METHODS {#sec1-1}
=====================

Search strategy {#sec2-1}
---------------

Studies were identified using a search strategy in PubMed database, EMBASE database, China National Knowledge Infrastructure, Wan Fang, and VIP databases. Search items were listed as follows: ("D-dimer"\[All Fields\]) AND ("liver cirrhosis" \[All Fields\]) AND ("portal vein thrombosis" \[All Fields\]). The last search was performed on July 20, 2014. When the same data were reported in more than one publication, only the studies with more complete data and more extensive interval of enrolment were included in the meta-analysis.

Data extraction {#sec2-2}
---------------

A data extraction sheet included authors, publication year, country where the study was conducted, period of enrolment, study design, inclusion and exclusion criteria, type of diseases (liver cirrhosis or cirrhotic portal hypertension after surgery), total sample size, demographic data (age and gender), Child--Pugh Score or Class, and number of patients with and without PVT.

Inclusion criteria {#sec2-3}
------------------

The participants of any age with diagnosis of liver cirrhosisAll observational studies, including cohort and case--control studies, regardless of the retrospective or prospective nature of the studyNo publication date or publication status restrictionsNo language restrictionsD-dimer levels were measured.

Exclusion criteria {#sec2-4}
------------------

Case reportsAnimal studiesReviews or comments on the significance of liver cirrhosisContents or indexesPatients with hepatocellular carcinoma or other malignancy, cholestatic liver diseases, Budd--Chiari syndrome, pancreatitis, preoperative had thrombosis, the use of anticoagulation or antiplatelet drugs, and recent abdominal traumaNoncomparative studiesStudies which did not report the D-dimer levelsStudies in which the data were not expressed as the mean value and standard deviationDuplicate studies.

Evaluation of study quality {#sec2-5}
---------------------------

The quality of included studies was evaluated according to the STROBE statement checklists ([www.strobe-statement.org](http://www.strobe-statement.org)). It included 22 items to evaluate the title and abstracts, introduction, methods, results, discussion, and funding \[[Supplementary Table 1](#T1){ref-type="table"}\].
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Data synthesis {#sec2-6}
--------------

The D-dimer levels were collected in cirrhotic patients with and without PVT. The difference of D-dimer levels between them was calculated as mean difference. A standardized mean difference (SMD) with 95% confidence interval (CI) was used to evaluate the association between D-dimer concentration and PVT in liver cirrhosis. A standardized value was employed, primarily because D-dimer level was measured by different units and methods in different studies. Then, the SMD of each study was combined to give a pooled SMD. An SMD \>0 favored the effect of increased D-dimer concentration on PVT, and a *P* \< 0.05 was considered statistically significant. Data were pooled using random-effect models. Heterogeneity between studies was assessed by using the *I*^2^ statistic (*I*^2^ \> 50% was considered as having substantial heterogeneity) and the χ^2^ test (*P* \< 0.10 was considered to represent statistically significant heterogeneity). The Egger test was performed to evaluate the presence of publication bias for all pooled values with 95%CI. All analyses were conducted using Stats Direct statistical software version 2.7.8 (Stats Direct Ltd, Sale, Cheshire, UK).

RESULTS {#sec1-2}
=======

Description of the included studies {#sec2-7}
-----------------------------------

A total of 284 studies were initially identified by the search strategy. Among them, 21 studies involving 602 cirrhotic patients with PVT and 1490 cirrhotic patients without PVT were eligible in the meta-analyses \[[Figure 1](#F1){ref-type="fig"}\].\[[@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21][@ref22][@ref23][@ref24][@ref25][@ref26][@ref27][@ref28][@ref29][@ref30][@ref31][@ref32]\] Baseline characteristics are summarized in [Table 1](#T2){ref-type="table"} and D-dimer concentration is summarized in [Table 2](#T3){ref-type="table"}. The quality of the included studies are demonstrated in [Supplementary Table 2](#T4){ref-type="table"}.
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Study characteristics: An overview
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Comparison of D-dimer concentration between cirrhotic patients with and without PVT: An overview
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###### 

Results of study quality
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Association between D-dimer concentrations and PVT in liver cirrhosis without surgery {#sec2-8}
-------------------------------------------------------------------------------------

D-dimer concentration between the PVT group and the non-PVT group was similar in three studies\[[@ref13][@ref19][@ref25]\] and significantly different in 11 studies.\[[@ref12][@ref15][@ref16][@ref17][@ref18][@ref21][@ref22][@ref24][@ref26][@ref28][@ref29]\] Additionally, the difference between the two groups was unclear in one study.\[[@ref32]\] Using a random-effects model, a meta-analysis demonstrated that the pooled SMD was significant (1.249, 95%CI = 0.740--1.758, *P* \< 0.0001), suggesting a higher D-dimer concentration in cirrhotic patients with PVT than in those without PVT \[[Figure 2](#F2){ref-type="fig"}\]. The heterogeneity among studies was significant (*I*^2^ = 93.6%, *P* \< 0.0001). Egger test implied no proof of publication bias (*P* = 0.205).
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Association between preoperative D-dimer concentration and PVT after the surgery of cirrhotic portal hypertension {#sec2-9}
-----------------------------------------------------------------------------------------------------------------

Preoperative D-dimer concentration between the PVT group and the non-PVT group was similar in all five studies.\[[@ref14][@ref20][@ref23][@ref30][@ref31]\] Using a random-effects model, a meta-analysis demonstrated that the pooled SMD was not significant (0.820, 95%CI = −0.122--0.286, *P* = 0.431), showing that D-dimer concentration was similar between the PVT group and the non-PVT group \[[Figure 3](#F3){ref-type="fig"}\]. The heterogeneity among studies was not significant (*I*^2^ = 0%, *P* = 0.721). Egger test implied no proof of publication bias (*P* = 0.179).
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Association between postoperative D-dimer concentration and PVT after the surgery of cirrhotic portal hypertension {#sec2-10}
------------------------------------------------------------------------------------------------------------------

Postoperative D-dimer concentration between the PVT group and the non-PVT group was significantly different in all four studies.\[[@ref14][@ref23][@ref27][@ref30]\] Using a random-effects model, a meta-analysis demonstrated that the pooled SMD was significant (2.505, 95%CI = 0.975--4.036, *P* = 0.0013), showing that D-dimer concentration was significantly higher in the PVT group than in the non-PVT group \[[Figure 4](#F4){ref-type="fig"}\]. The heterogeneity among studies was significant (*I*^2^ = 96%, *P* \< 0.0001). Egger test implied no proof of publication bias (*P* = 0.153).
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Association between 1^st^ postoperative D-dimer concentration and PVT after the surgery of cirrhotic portal hypertension {#sec2-11}
------------------------------------------------------------------------------------------------------------------------

First postoperative D-dimer concentration between the PVT group and the non-PVT group was similar in one study\[[@ref20]\] and significantly different in the other study.\[[@ref31]\] Using a random-effects model, a meta-analysis demonstrated that the pooled SMD was not significant (0.137, 95%CI = −0.827--1.101, *P* = 0.781), showing that D-dimer concentration was similar between the PVT group and the non-PVT group \[[Figure 5](#F5){ref-type="fig"}\]. The heterogeneity among studies was significant (*P* = 0.0096). Egger test could not evaluate the publication bias.
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Association between 7^th^ postoperative D-dimer concentration and PVT after the surgery of cirrhotic portal hypertension {#sec2-12}
------------------------------------------------------------------------------------------------------------------------

Seventh postoperative D-dimer concentration between the PVT group and the non-PVT group was significantly different in the two studies.\[[@ref20][@ref31]\] Using a random-effects model, a meta-analysis demonstrated that the pooled SMD was significant (1.224, 95%CI = 0.277--2.171, *P* = 0.0113), suggesting a higher D-dimer concentration in cirrhotic patients with PVT than in those without PVT \[[Figure 6](#F6){ref-type="fig"}\]. The heterogeneity among studies was significant (*P* = 0.0212). Egger test could not evaluate the publication bias.
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DISCUSSION {#sec1-3}
==========

D-dimer is produced during the fibrinolysis. D-dimer testing is cheap and readily available, and importantly, it has a high negative predictive value and sensitivity for deep vein thrombosis and pulmonary embolism.\[[@ref33]\] At present, it has been widely used for the diagnostic workup of suspected venous thromboembolism in clinical practice. Evidence suggests that a negative D-dimer in the combination with clinical probability tools can effectively rule out the diagnosis of deep vein thrombosis and pulmonary embolism, which reduce the need for ultrasound testing.\[[@ref34][@ref35]\] However, the role of D-dimer in the diagnosis of PVT in liver cirrhosis remained unclear. The present study for the first time systematically reviewed the currently available data to clarify the issue. The most important finding was that an increased D-dimer concentration was associated with a higher risk of PVT in liver cirrhosis in the absence of surgery, which potentially suggested that D-dimer should be a diagnostic marker for PVT in cirrhotic patients. However, the accurate cutoffs of D-dimer for predicting the development of PVT were largely lacking. In one included study, Zhang *et al.* calculated the area under curve (AUC) of D-dimer for the diagnosis of PVT.\[[@ref28]\] They found that D-dimer had the largest AUC of 0.868, followed by Child--Pugh Score of 0.823, diameter of main portal vein of 0.810, and portal vein velocity of 0.756. Another included study also demonstrated that the AUC of D-dimer was 0.782 for the diagnosis of PVT in all cirrhotic patients, and the cutoff value was 0.52 mg/dL.\[[@ref36]\] The subgroup analyses according to the Child--Pugh class further demonstrated that the AUC of D-dimer was 0.963, 0.75, and 0.698 in Child--Pugh class A, B, and C patients, respectively. The cutoff value was heterogeneous, such as 0.52, 0.56, 1.12 mg/dL in Child--Pugh Class A, B, and C patients, respectively.

Considering a high risk of PVT in cirrhotic patients undergoing the portal hypertension-related surgery, we analyzed the association between D-dimer concentration and PVT in such patients. Ideally, D-dimer should have an early predictive probability of developing PVT. However, we found that the postoperative value of D-dimer, but not preoperative value of D-dimer, could predict the development of PVT after surgery. In addition, the 7^th^ postoperative value of D-dimer, but not 1^st^ postoperative value of D-dimer, was associated with the development of PVT after surgery. Because PVT developed within the 7^th^ postoperative days, these unexpected findings might suggest that the change in the D-dimer concentrations was accompanied by the occurrence of PVT after surgery; however, a simple D-dimer test could not provide any possibilities of early prediction of PVT.

The study had several limitations as follows. First, we could only establish the association between D-dimer and the development of PVT in liver cirrhosis. However, we did not identify the negative predictive value of D-dimer in ruling out PVT. Second, a clinical probability tool could further stratify the risk for the assessment of venous thromboembolism and pulmonary embolism, thereby increasing the negative predictive value of D-dimer tests.\[[@ref34][@ref37]\] However, no clinical probability tools were established for the risk of the assessment of PVT. Third, only a few studies explored the association between D-dimer and PVT after portal hypertension-related surgery, especially the 1^st^ and 7^th^ postoperative value of D-dimer. Thus, the conclusions needed to be confirmed. Fourth, a majority of the reviewed studies were of poor quality, which potentially influenced the reliability of these findings.

In conclusion, D-dimer might be regarded as a diagnostic marker of PVT in liver cirrhosis, but further work should identify the accurate cutoff value of D-dimer for excluding the diagnosis of PVT. In addition, postoperative D-dimer testing is worthwhile for the diagnosis of PVT after portal hypertension-related surgery in liver cirrhosis, but the timing of D-dimer testing after surgery should be further explored.
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